Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yale SEVEN
NCT05279092Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Sep 2022
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone sodium phosphate, methylprednisolone in postoperative pain, sponsored by Yale University. Started Sep 2022; status: recruiting.
02
Drugs
dexamethasone sodium phosphatemethylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05279092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05279092.